Filardo et al. have reported that GPER mediates EGFR transactivation and its downstream signaling through the release of surface-associated heparin-binding EGF (HB-EGF) from its precursor protein in breast cancer cells [25]. The gene discussed is EGFR; the disease is breast carcinoma.